| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Century Therapeutics, Inc. | Chief Financial Officer | Common Stock | 253,533 | $377,764 | $1.49 | 01 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | 01 Nov 2023 | 1 | -$30,937 | 4 | Chief Financial Officer | 03 Nov 2023, 16:04 |
| IPSC | Century Therapeutics, Inc. | 15 May 2023 | 1 | $0 | 4 | Chief Financial Officer | 17 May 2023, 16:32 |
| IPSC | Century Therapeutics, Inc. | 02 Feb 2023 | 4 | $0 | 4 | Chief Business Officer | 06 Feb 2023, 17:49 |
| IPSC | Century Therapeutics, Inc. | 25 Jan 2022 | 1 | $0 | 4 | Chief Business Officer | 27 Jan 2022, 15:51 |
| IPSC | Century Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Chief Business Officer | 17 Jun 2021, 17:03 |